SSY Group Limited

HKSE 2005.HK

SSY Group Limited EPS (Diluted) for the year ending December 31, 2023: USD 0.06

SSY Group Limited EPS (Diluted) is USD 0.06 for the year ending December 31, 2023, a 15.81% change year over year. EPS (Diluted) reflects the company's earnings per share adjusted for the potential dilution that could occur if all convertible securities were converted to common stock, providing a more conservative profitability measure.

SSY Group Limited EPS (Diluted) for the year ending December 31, 2022 was USD 0.05, a 45.90% change year over year.
SSY Group Limited EPS (Diluted) for the year ending December 31, 2021 was USD 0.03, a 29.27% change year over year.
SSY Group Limited EPS (Diluted) for the year ending December 31, 2020 was USD 0.03, a -45.68% change year over year.
SSY Group Limited EPS (Diluted) for the year ending December 31, 2019 was USD 0.05, a 23.98% change year over year.

Key data

Date	EPS (Diluted)	Shares (Diluted, Weighted)	Shares (Basic, Weighted)	Revenue

HKSE: 2005.HK

SSY Group Limited

CEO	Mr. Jiguang Qu
IPO Date	Dec. 20, 2005
Location	Hong Kong
Headquarters	Central Plaza
Employees	5,800
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Cleaning Supplies Containers & Packaging Drugstores & Retail Pharmacies Non-Alcoholic Beverages Personal Care Plastics

Description

SSY Group Limited, an investment holding company, researches, develops, manufactures, and sells various pharmaceutical products to hospitals and distributors in the People's Republic of China and internationally. The company offers intravenous infusion solutions, including non-PVC soft bags, upright soft bags, PP plastic bottles, and glass bottle infusion solutions, as well as ampoule injections. It also provides small volume injections, oral preparations, Chinese medicine preparations, and biological preparations, as well as bulk pharmaceutical products and medical materials. In addition, the company is involved in the research, development, and consulting of pharmaceutical technology; provision of logistics services for pharmaceutical products; and food, beverages, and catering business. It sells its products under Shimen brand name. The company was formerly known as Lijun International Pharmaceutical (Holding) Co., Ltd. and changed its name to SSY Group Limited in May 2015. The company was incorporated in 2004 and is headquartered in Wanchai, Hong Kong. SSY Group Limited is a subsidiary of China Pharmaceutical Co., Ltd.

Key trends

Past 5 years